Delhi: 81 sites identified for COVID-19 vaccination
Authorities on Thursday released a list of 81 sites that will be part of the immunization exercise. Covishield will be administered at 75 centers, while COVAXIN will be given at the remaining facilities. The sites, with nearly an even split of government and private hospitals, include six central government facilities - AIIMS, Safdarjung Hospital, RML Hospital, Kalawati Saran Children Hospital, and two ESI hospitals.
Facilities span around all 11 districts
Apart from the six government hospitals, the rest 75 centres, spanning all 11 districts of Delhi, include Delhi government-run facilities, such as LNJP Hospital, GTB Hospital, Rajiv Gandhi Super Speciality Hospital, DDU Hospital, BSA Hospital, Delhi State Cancer Institute, and ILBS Hospital. The private facilities identified for vaccination include Max Hospital, Fortis Hospital, Apollo Hospital and Sir Ganga Ram Hospital.
COVAXIN sites are not clear though
"Delhi has now a total of 81 session sites, 75 for administering Covishield vaccine and six for COVAXIN, on the vaccination roll-out day," a senior official in the Delhi Health Department said. However, he didn't clarify which of these hospitals will be COVAXIN sites.
2.74 lakh doses received by Delhi Government so far
Addressing an online media briefing, Chief Minister Arvind Kejriwal on Thursday said the city government has received a total of 2.74 lakh doses of the vaccine so far from the Centre, which would be sufficient to cater to 1.2 lakh healthcare workers. Kejriwal also said the Centre has given 10 percent extra in stock, in case of any mishappening, like damage to vials.
Delhi Government prepared for the first phase of immunization
The first batch of Oxford Covishield vaccine containing 2.64 lakh doses had reached Delhi's central storage facility at Rajiv Gandhi Super Speciality Hospital on Tuesday amid high security, officials earlier said. Later, 20,000 doses of COVAXIN, had arrived at the RGSSH on Wednesday. The Delhi government is all set for the first phase of the immunization exercise with healthcare workers in the front line.
All teams, people of Delhi ready for vaccination program: Kejriwal
India's drugs regulator has approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed COVAXIN of Bharat Biotech for restricted emergency use in the country. Ahead of the media interaction, Kejriwal held a review meeting on the vaccination roll-out plan. He said all the teams are ready for the COVID-19 vaccination program, and so are the people of Delhi.
